Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE COMPOSITIONS

  • Read more about ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE COMPOSITIONS
US Patent 5,882,651
Filed on 1995-05-30

ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE COMPOSITIONS

  • Read more about ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE COMPOSITIONS
US Patent 5,922,326
Filed on 1994-10-21

ADMINISTRATION OF MONOCLONAL ANTIBODIES AGAINST RESPIRATORY VIRUSES

  • Read more about ADMINISTRATION OF MONOCLONAL ANTIBODIES AGAINST RESPIRATORY VIRUSES
US Application 08/389,982
Filed on 1995-02-14

MODIFIED MYELIN BASIC PROTEIN MOLECULES

  • Read more about MODIFIED MYELIN BASIC PROTEIN MOLECULES
US Patent 7,041,503
Filed on 1995-05-02

BINDING DOMAINS FROM PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM ERYTHROCYTE BINDING PROTEINS

  • Read more about BINDING DOMAINS FROM PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM ERYTHROCYTE BINDING PROTEINS
US Patent 5,849,306
Filed on 1995-12-07

HYBRID PICORNAVIRUSES EXPRESSING CHLAMYDIAL EPITOPES

  • Read more about HYBRID PICORNAVIRUSES EXPRESSING CHLAMYDIAL EPITOPES
US Application 08/246,983
Filed on 1993-05-13

VACCINE AGAINST HEPATITIS A VIRUS

  • Read more about VACCINE AGAINST HEPATITIS A VIRUS
US Patent RE37,381
Filed on 1995-09-06

ATTENUATED HUMAN ROTAVIRUS VACCINE

  • Read more about ATTENUATED HUMAN ROTAVIRUS VACCINE
US Patent 7,150,984
Filed on 1995-07-11

CHIMERIC NUCLEIC ACID SEQUENCES ENCODING ATTENUATED HEPATITIS A VIRUSES HAVING AT LEAST ONE MUTATION IN THE 2A GENE AND THE USE OF...

  • Read more about CHIMERIC NUCLEIC ACID SEQUENCES ENCODING ATTENUATED HEPATITIS A VIRUSES HAVING AT LEAST ONE MUTATION IN THE 2A GENE AND THE USE OF...
US Application 08/547,482
Filed on 1995-10-24

Methods of Immunization Using Recombinant Poxviruses Having Foreign DNA Expressed Under The Control of Poxvirus Regulatory Sequences

  • Read more about Methods of Immunization Using Recombinant Poxviruses Having Foreign DNA Expressed Under The Control of Poxvirus Regulatory Sequences
US Patent 7,045,136
Filed on 1995-06-06

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 560
  • Page 561
  • Page 562
  • Page 563
  • Page 564
  • Page 565
  • Page 566
  • Page 567
  • Page 568
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health